Sign in
Not yet taking people in United StatesEarly phase 1

Cannabigerol Gummies for Recovery After Bladder Removal Surgery for Bladder Cancer

Tests cannabigerol gummies around surgery in adults having bladder cancer removed.

Key facts

Who runs it
Stanford University
Where
Palo Alto, United StatesSee the site
Trial code
Registry title
The Effects of Cannabis on Post Operative Recovery After Radical Cystectomy
Status
Not yet recruiting
Phase
Early phase 1
People taking part
20 people, planned
Starts
Jul 2027
Expected to end
May 2028
Type of study
Interventional
Treatments tested
  • Cannabigerol
Record updated
23 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults in California with non-metastatic bladder cancer who are about to have radical cystectomy with urinary diversion. They will take cannabigerol gummies around the time of surgery.

Age
18 years or older
Sex
Men and women can join
Disease stage
Non-metastatic bladder cancer, scheduled for radical cystectomy and urinary diversion
Earlier treatment
No CBD, cannabigerol or THC use in the last 30 days

Main reasons for not taking part

  • History of substance abuse
  • History of psychosis or schizophrenia
  • CBD, cannabigerol or THC use in the last 30 days
  • Pregnant or breastfeeding
  • Heart attack or acute coronary syndrome in the 90 days before surgery

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • 18 years of age or older
  • Non-metastatic bladder cancer scheduled to undergo radical cystectomy and urinary diversion
  • Patient is able to understand consent and is willing and able to provide written informed consent
  • Patient makes their own medical decisions
  • Lives in state of California
  • Patient is able and willing to refrain from using any non-study cannabis during the screening and treatment phases of the study
  • Females of childbearing potential to utilize an acceptable birth control method while consuming the gelatin-based chewable medication
  • Be able to read and understand the study questionnaires
  • Patient agrees to not to operate heavy machinery or engage in activities that require mental alertness while taking the gelatin-based chewable cannabigerol medication, as these substances may cause drowsiness

Who cannot take part

  • Patients who have had heart attack or acute coronary syndrome in the 90 days prior to surgery
  • History of substance abuse
  • History of psychosis or schizophrenia
  • CBD or Cannabigerol usage in the last 30 days
  • THC usage in the last 30 days
  • Pregnant or breastfeeding individuals

Where in United States

  • Stanford UniversityPalo Alto, United StatesContact: Jay ShahNot yet recruiting

About the trial

What the trial wants to find out

This will be an open-label, single group supportive care pilot study in which patients are given cannabinoid gummies in the perioperative setting to alleviate RC/UD symptoms and improve quality of life. The primary objective will be to evaluate the safety and tolerability of a cannabigerol supplement used perioperatively (from 14 days prior to surgery to 30 days following surgery) by patients undergoing radical cystectomy with urinary diversion (RC/UD).

The group in the trial

  • Cannabigerol GummiesTreatment being tested

    Participants will receive cannabigerol gummies (oral, gelatin-based chewable formulation), 25 milligrams per gummy. Dosing will begin approximately 2 weeks prior to cystectomy with urinary diversion at 12.5 milligrams (one-half gummy) three times daily after meals. Based on tolerability, the dose may be increased to 25 milligrams (one gummy) three times daily or reduced to 6.25 milligrams (one-quarter gummy) 1 to 3 times daily. Treatment will continue through the perioperative period and up to 30 days postoperatively.

    Treatment: Cannabigerol

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Effects of Cannabis on Post Operative Recovery After Radical Cystectomy
Plain-language title
Cannabigerol Gummies for Recovery After Bladder Removal Surgery for Bladder CancerGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 13 November 2026.
Record updated
23 July 2026